doi: 10.3390/nu11010070
The study reveals that the SLC25A39 transporter, which imports glutathione into mitochondria, is essential for cancer spread, and elevated SLC25A39 expression correlates with poorer survival outcomes in breast cancer patients, suggesting potential therapeutic targeting opportunities
According to the FDA, the data showed no increased risk of suicide, depression, anxiety, or related psychiatric effects compared to placebo, leading the agency to conclude that the existing warnings are not supported by the evidence
Capsule Dosing Schedule Cycle length: 8 weeks on, 4 weeks off is a common research-protocol pattern for ERR agonist studies
Tests like GI-MAP or comprehensive stool panels can reveal useful information, but negative tests do not rule out significant clinical dysfunction
For others, it falls short of the threshold where cardiovascular and metabolic benefits are established